Key Points
- Director Jack Lazar sold 10,000 shares of Astera Labs on June 4 at an average price of $355.17, totaling about $3.55 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
- Astera Labs recently posted strong quarterly results, beating earnings and revenue expectations with EPS of $0.61 and revenue of $308.36 million, up 93.5% year over year. The company also guided Q2 2026 EPS to $0.68-$0.70.
- Analyst sentiment remains positive overall, with 12 Buy ratings and 11 Hold ratings and an average price target of $233.75. However, some firms have recently trimmed their views, including a downgrade from Northland Securities to market perform.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Jack Lazar sold 10,000 shares of Astera Labs stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Astera Labs Stock Performance
NASDAQ:ALAB opened at $346.33 on Tuesday. The stock's 50-day simple moving average is $217.60 and its 200 day simple moving average is $173.27. The company has a market cap of $59.36 billion, a P/E ratio of 234.01, a P/E/G ratio of 4.20 and a beta of 3.94. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $372.37.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business's revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the company. Evercore reissued an "outperform" rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Needham & Company LLC boosted their price target on Astera Labs from $220.00 to $260.00 and gave the stock a "buy" rating in a research report on Wednesday, May 6th. Northland Securities downgraded Astera Labs from an "outperform" rating to a "market perform" rating in a research report on Tuesday, May 26th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research report on Friday, May 1st. They set a "neutral" rating and a $153.00 price target on the stock. Finally, UBS Group initiated coverage on Astera Labs in a research report on Tuesday, April 21st. They set a "neutral" rating and a $180.00 price target on the stock. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $233.75.
View Our Latest Stock Report on ALAB
Institutional Investors Weigh In On Astera Labs
Institutional investors have recently made changes to their positions in the company. Assetmark Inc. boosted its holdings in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company's stock worth $25,000 after acquiring an additional 101 shares during the period. Reflection Asset Management bought a new stake in shares of Astera Labs in the fourth quarter valued at approximately $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock valued at $32,000 after buying an additional 152 shares during the period. Hilltop National Bank boosted its stake in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after buying an additional 100 shares during the period. Finally, Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the fourth quarter valued at approximately $33,000. Institutional investors own 60.47% of the company's stock.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
